Placebos, Full Disclosure, and Trust: The Risks and Benefits of Disclosing Risks and Benefits

American Journal of Bioethics 15 (10):13-14 (2015)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

DOI

10.1080/15265161.2015.1074315

Links

PhilArchive

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Risk-Benefit Analysis: From a Logical Point of View. [REVIEW]Georg Spielthenner - 2012 - Journal of Bioethical Inquiry 9 (2):161-170.
DTC Advertising Harms Patients and Should Be Tightly Regulated.Peter Lurie - 2009 - Journal of Law, Medicine and Ethics 37 (3):444-450.
Problems in deceptive medical procedures: an ethical and legal analysis of the administration of placebos.B. Simmons - 1978 - Journal of Medical Ethics 4 (4):172-181.
On Deontological Justifications of Nuclear Risks.George Timothy Draper - 1989 - Dissertation, University of California, Irvine
The Merits of Procedure-Level Risk-Benefit Assessment.Anna Westra & Inez de Beaufort - 2011 - IRB: Ethics & Human Research 33 (5):7-13.
The Ethical Problems of the Open Label Extension Study.Kenneth Craig Micetich - 1996 - Cambridge Quarterly of Healthcare Ethics 5 (3):410.
A question of balance or blind faith?: Scientists' and science policymakers' representations of the benefits and risks of nanotechnologies. [REVIEW]Alan Petersen & Alison Anderson - 2007 - NanoEthics 1 (3):243-256.
Filling the gaps in the risks vs. benefits of mammalian adult-cell cloning: Taking Bernard Rollin's philosophy its next step.Lantz Miller - 1998 - Journal of Agricultural and Environmental Ethics 11 (1):1-16.
Gene technology, food production, and public opinion: A UK study. [REVIEW]Paul Sparks, Richard Shepherd & Lynn J. Frewer - 1994 - Agriculture and Human Values 11 (1):19-28.
Male circumcision and the enhancement debate: harm reduction, not prohibition.Julian Savulescu - 2013 - Journal of Medical Ethics 39 (7):416-417.
Defending human enhancement technologies: unveiling normativity.Inmaculada de Melo-Martin - 2010 - Journal of Medical Ethics 36 (8):483-487.
Operant learning and selectionism: Risks and benefits of seeking interdisciplinary parallels.Richard W. Malott - 2001 - Behavioral and Brain Sciences 24 (3):544-544.
The commercialization of university-based research: Balancing risks and benefits.Timothy Caulfield & Ubaka Ogbogu - 2015 - BMC Medical Ethics 16 (1):1-7.
Some ethical issues arising from polio eradication programmes in india.Yash Paul & Angus Dawson - 2005 - Bioethics 19 (4):393–406.
Children's capacity to agree to psychological research: Knowledge of risks and benefits and voluntariness.Rona Abramovitch, Jonathan L. Freedman, Kate Henry & Michelle Van Brunschot - 1995 - Ethics and Behavior 5 (1):25 – 48.

Analytics

Added to PP
2015-10-20

Downloads
408 (#46,379)

6 months
91 (#44,776)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

Peter H. Schwartz
Indiana University Purdue University, Indianapolis

Citations of this work

No citations found.

Add more citations

References found in this work

Principles of biomedical ethics.Tom L. Beauchamp - 1994 - New York: Oxford University Press. Edited by James F. Childress.
The silent world of doctor and patient.Jay Katz - 1984 - Baltimore: Johns Hopkins University Press.
Placebo Effects and Informed Consent.Mark Alfano - 2015 - American Journal of Bioethics 15 (10):3-12.

View all 6 references / Add more references